Latest News
Sisram Medical s Profhilo registration application receives Chinese regulatotry acceptance for facial indication
20 October 2026 - Sisram Medical Ltd (HKG: 1696), a China-based global wellness group offering Energy-Based Devices (EBDs), injectables, and other complementary solutions, announced on Monday that China's National Medical Products Administration...
Oracle partners AstraZeneca for AI-enabled healthcare innovation
20 October 2026 - US-based tech firm Oracle Corporation (NYSE: ORCL) announced on Tuesday an agreement with UK-based pharmaceutical company AstraZeneca (LON: AZN) to explore how AI and real-world data can help clinicians identify eligible patients fo...
Eli Lilly and Company reports positive one-year results for Omvoh in paediatric ulcerative colitis
19 October 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) reported on Mondy that it has recorded positive one-year Phase 3 results for Omvoh (mirikizumab-mrkz) in children and adolescents with moderately to severely active ulcerative colit...
Telix and Ekalia to develop US astatine-211 production
...
AbbVie's dual-targeting Crohn's disease therapy outperforms monotherapies in Phase IIa trial
19 October 2026 - Pharmaceutical research and development company AbbVie (NYSE: ABBV) reported on Monday that its investigational dual-targeting therapy ABBV-466 achieved higher endoscopic remission rates than either anti-IL-23 or anti-α4β...